Yesterday, the Food and Drug Administration requested that all Ranitidine products be removed from the market due to concerns that the drug contains a known carcinogen.
The known carcinogen, NDMA, can increase the risk of cancer.
Ranitidine, more commonly known by brand name Zantac, is a drug that can be prescribed by a doctor or purchased over-the-counter. This drug is used to treat stomach ulcers, heart burn, esophagitis, and gastroesophageal reflux disease (GERD.)
Zantac, along with other brands including Wal-Zan 150, Wal-Zan 75, Zantac Maximum Strength, Acid Control (rainitidine), Acid Reducer (ranitidine) and Zantac 75 may all be affected by this recall.
If you are prescribed this medicine, you may wish to speak to your doctor about your continued use of this medication.
If you have Zantac or other ranitidine products in your possession, please refer to the FDA instructions on how to dispose of the affected drugs.
If you or someone you know has been diagnosed with cancer after using Zantac, please contact me at kwaters@jeffgreenlaw.com to discuss your possible claim.